Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18210866 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL29981733 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL8854310 | 0.97 | LMNA (0.69) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL9231331 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL20567548 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL23832483 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL12344326 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL22283330 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL6078811 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL6078816 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586135-A | Biomass-based surfactant thickener and preparation method thereof | 中国科学院化学研究所 | 2024-02-23 | — | — | CN | claimed |
| CN-117586135-A | Biomass-based surfactant thickener and preparation method thereof | 中国科学院化学研究所 | 2024-02-23 | — | — | CN | disclosed |
| US-20190144411-A1 | Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereof | MSN LABORATORIES PRIVATE LIMITED (IN) | 2019-05-16 | — | — | US | disclosed |
| US-20170029398-A1 | PROCESS FOR THE PREPARATION OF (1S)-1,5-ANHYDRO-1-C-{4-CHLORO-3-4[(4-ETHOXYPHENYL)METHYL]PHENYL]-GLUCITOL AND ITS SOLVATE THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2017-02-02 | — | — | US | disclosed |
| EP-3114115-A2 | PROCESS FOR THE PREPARATION OF (1S)-1,5-ANHYDRO-1-C-[4-CHLORO-3-[(4-ETHOXYPHENYL)METHYL]PHENYL]-D-GLUCITOL AND ITS SOLVATE THEREOF | MSN Laboratories Private Limited (IN) | 2017-01-11 | — | — | EP | disclosed |
| WO-2015132803-A2 | PROCESS FOR THE PREPARATION OF (1S)-1,5-ANHYDRO-1-C-[4-CHLORO-3-[(4-ETHOXYPHENYL)METHYL]PHENYL]-D-GLUCITOL AND ITS SOLVATE THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2015-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029398-A1 | PROCESS FOR THE PREPARATION OF (1S)-1,5-ANHYDRO-1-C-{4-CHLORO-3-4[(4-ETHOXYPHENYL)METHYL]PHENYL]-GLUCITOL AND ITS SOLVATE THEREOF | ADH1C, ALG1, UGGT1 | TDP1 1109/4885LMNA 2241/4885L3MBTL1 2150/4885 |
| US-20190144411-A1 | Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereof | ADH1C, ALG1, UGGT1 | TDP1 983/4885LMNA 2041/4885L3MBTL1 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.